Azitra AZTR
NYSE AZTR
$0.13 +0.01 (+4.81%)
At close: Aug 21, 2026 · 4:00 PM EDT

Azitra (AZTR) Cash & Equivalents (2022 - 2026)

Azitra's (AZTR) quarterly Cash & Equivalents came in at $10.1 million in Q1 2026, up 213.44% YoY from $3.2 million in Q1 2025, and up 386.01% on a QoQ basis from $2.1 million in Q4 2025.

Azitra (AZTR) Cash & Equivalents (2022 - 2026) Analysis & Trends

Azitra (AZTR) has 5 years of Cash & Equivalents data on file, last reported at $10.1 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 213.44% year-over-year to $10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 213.44% YoY) and the FY2025 annual result came in at $2.1 million, down 54.59% from the prior year.
  • Cash & Equivalents advanced to $10.1 million in Q1 2026, from $2.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $10.1 million in Q1 2026 to a low of $803082.0 in Q2 2024.
  • A 5-year average of $3.8 million and a median of $3.2 million in 2025 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents sank 87.23% — and 2026, when it jumped 213.44%.
  • Tracing AZTR's Cash & Equivalents over 5 years: stood at $3.5 million in 2022, then plunged by 48.58% to $1.8 million in 2023, then surged by 153.61% to $4.6 million in 2024, then slumped by 54.59% to $2.1 million in 2025, then soared by 386.01% to $10.1 million in 2026.
  • The last three Cash & Equivalents figures came in at $10.1 million (Q1 2026), $2.1 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Azitra 2.53 Mn 2.53 Mn - 6.73 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.73 Mn
Mar 31, 2026 10.05 Mn
Dec 31, 2025 2.07 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.05 Mn
Mar 31, 2025 3.21 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 7.26 Mn
Jun 30, 2024 803,082.00
Mar 31, 2024 3.00 Mn
Dec 31, 2023 1.80 Mn
Sep 30, 2023 4.40 Mn
Jun 30, 2023 6.29 Mn
Dec 31, 2022 3.49 Mn